3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Withdrawn
1
Terminated
1
Sponsor Class
OTHER
25
INDUSTRY
4
Study Type
Observational
4
Sponsor
Cancer Type
Genitourinary
2
Breast
2
Conditions
Neoplasms
9
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
6
Breast Neoplasms
6
Prostatic Neoplasms
5
Papillomavirus Infections
5
Ovarian Neoplasms
4
Neoplastic Cells, Circulating
4
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
3
Lung Neoplasms
3
Melanoma
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Carcinoma, Hepatocellular
2
Thymic aplasia
1
Stomach Neoplasms
1
Solid Tumor, Adult
1
Small Cell Lung Carcinoma
1
Respiratory Distress Syndrome
1
Recurrence
1
Rectal Neoplasms
1
Radiation Injuries
1
Pulmonary Disease, Chronic Obstructive
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Opioid-Related Disorders
1
Interventions
Blood Specimen Collection
4
Zoledronic Acid
1
Standard of Care
1
Diphosphonates
1
Data Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neoplastic Cells, Circulating
×
Blood Specimen Collection
×
Clear all
NCT05437679
2023-09-05
CHARTER
Angle plc
Terminated
9 enrolled
NCT03427450
2023-06-05
HOMING
Angle plc
Completed
421 enrolled
NCT02742259
2019-03-26
VPCA-B+PIV
Celsee Diagnostics
Withdrawn
NCT01701050
2017-03-08
COMETI P2
Janssen Diagnostics, LLC
Completed
121 enrolled